Braster S.A.

Equities

BRA

PLBRSTR00014

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:55:54 2024-05-15 EDT			5-day change	1st Jan Change
0.58 ^PLN	0.00%		0.00%	0.00%

2023	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2020

May 30, 2021 at 06:46 pm

Braster S.A. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced operating loss was PLN 7.189 million compared to PLN 13.717 million a year ago. Net loss was PLN 8.088 million compared to PLN 15.537 million a year ago.

Latest news about Braster S.A.

Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29	CI
Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-03	CI
Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-02	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-02	CI
Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-27	CI
Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-24	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-02	CI
Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-29	CI
Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-30	CI
An unknown buyer acquired 21.38% stake in Braster S.A. from Carom Sp. z o.o.	21-09-22	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
Braster Seeks To Raise Capital	18-07-06	CI
Braster S.A. announced that it has received PLN 0.3 million in funding	17-08-10	CI
Braster S.A. announced that it expects to receive PLN 0.3 million in funding	17-04-19	CI
Braster Negotiates Acquisitions	17-03-08	CI
Braster S.A. announced that it has received funding from Towarzystwo Funduszy Inwestycyjnych PZU SA	16-07-06	CI
Dom Maklerski Banku Ochrony Srodowiska S.A. sold 5.76% stake in Braster S.A..	16-06-30	CI
Medi-Koncept Sp. z o.o. sold 3.15% stake in Braster Spólka Akcyjna.	15-02-16	CI
Tadeusz Wesolowski acquired additional 4.3% stake in Braster Spólka Akcyjna.	15-02-16	CI

Chart Braster S.A.

Duration

Period

More charts

Company Profile

Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
BRASTER S.A.	0.00%	4.32M
EXACT SCIENCES CORPORATION	-27.90%	9.96B
GUARDANT HEALTH, INC.	-4.81%	3.03B
IOVANCE BIOTHERAPEUTICS, INC.	+31.37%	3B
BGI GENOMICS CO., LTD.	-14.73%	2.18B
VERACYTE, INC.	-14.39%	1.76B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+70.99%	1.42B
CAREDX, INC	+23.17%	794M
SEEGENE, INC.	-2.18%	756M
CURIOX BIOSYSTEMS CO., LTD	+3.18%	305M

Bio Diagnostics & Testing